Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.4000
-0.0250 (-5.88%)
Mar 31, 2025, 2:27 PM EDT - Market open
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $15.34 million as of March 31, 2025. Its market cap has decreased by -65.18% in one year.
Market Cap
15.34M
Enterprise Value
-5.82M
1-Year Change
-65.18%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $15.34M, a decrease of -97.78%. That is a compound annual growth rate of -60.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 16.29M | -20.44% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 732.25B |
| UnitedHealth Group | 478.46B |
| Johnson & Johnson | 398.76B |
| AbbVie | 367.38B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 228.51B |
| AstraZeneca | 225.46B |
| Merck & Co. | 225.42B |